Claudia Valverde
Hospital Vall d'Hebron · Hospital Universitari Vall d'Hebrón · Hospitals de la Vall de Hebron
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Claudia Valverde as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:29 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05146440 · Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid TumorGrupo Espanol de Investigacion en Sarcomas · recruiting · Advanced Soft-tissue Sarcoma, Advanced L-sarcomas, Other Advanced Sarcomas · principal investigator
- Ph2NCT05131386 · Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasGrupo Espanol de Investigacion en Sarcomas · unknown · Soft Tissue Sarcoma, Bone Tumors, Small Round-cell Sarcomas · principal investigator
- Ph1/Ph2NCT03277924 · Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasGrupo Espanol de Investigacion en Sarcomas · completed · Soft Tissue Sarcoma, Bone Sarcoma · principal investigator
- Ph2NCT03242382 · Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.Grupo Espanol de Investigacion en Sarcomas · unknown · Soft-tissue Sarcoma, Osteosarcoma, Chordoma · principal investigator
- Ph2NCT01692496 · Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical TrialGrupo Espanol de Investigacion en Sarcomas · completed · Advanced and / or Metastatic Liposarcoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:29 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.J Immunother Cancer · 2020160 citationsRCR 6.7
- 50 citationsRCR 1.5
- Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.Eur J Cancer · 201244 citationsRCR 1.0
- A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.Clin Cancer Res · 202540 citationsRCR 9.2
- Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.Br J Cancer · 201734 citationsRCR 1.2
- Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.Clin Cancer Res · 201832 citationsRCR 1.2
- A new short uncemented, proximally fixed anatomic femoral implant with a prominent lateral flare: design rationals and study design of an international clinical trial.BMC Musculoskelet Disord · 200831 citationsRCR 1.7
- Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.Cancer · 202530 citationsRCR 7.6
- 28 citationsRCR 5.8
- 25 citationsRCR 2.6